Lion Point Capital »

Enphys Acquisition Corp shares owned by Lion Point Capital

Quarter-by-quarter ownership of Enphys Acquisition Corp (NFYS) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Enphys Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Enphys Acquisition Corp held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enphys Acquisition Corp by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $834k 78k 10.67

More positions owned by Lion Point Capital

Semtech Corporation (SMTC)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Marinus Pharmaceuticals Com New (MRNS)
Ardelyx (ARDX)
Milestone Pharmaceuticals (MIST)
Harpoon Therapeutics Com New
Burgerfi International (BFI)
Kiniksa Pharmaceuticals Com Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Battalion Oil Corp (BATL)
Cymabay Therapeutics
Fennec Pharmaceuticals (FENC)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Enphys Acquisition Corp Cl A Ord Shs (NFYS)
Syndax Pharmaceuticals (SNDX)

View all positions for Lion Point Capital

Top funds holding Enphys Acquisition Corp

Berkley W R
Westchester Capital Management
Wolverine Asset Management
Fir Tree
Cowen And Company
Teacher Retirement System Of Texas
Polar Securities
Centiva Capital
Glazer Capital
Vivaldi Asset Management
Kim
Exos TFP Holdings
Crystalline Management
Alpine Partners VI
Lion Point Capital

View all funds holding Enphys Acquisition Corp